APO Research
Talk to an analyst

APO RESEARCH · REPORT

Valpromide

Compare research editions
View pricing & licenses

Selected research

Market Analysis & Forecast

Global Valpromide Market Analysis and Forecast 2026-2032

2 January 2026194 pages

Choose your research edition.

Industry ResearchValpromide Industry Research Report 2026119 pages · $2,950 USDIndustry Growth & TrendsGlobal Valpromide Industry Growth and Trends Forecast to 203293 pages · $3,450 USDMarket StructureGlobal Valpromide Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032180 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Valpromide Market Outlook and Growth Opportunities 2026199 pages · $4,250 USDMarket Analysis & ForecastGlobal Valpromide Market Analysis and Forecast 2026-2032194 pages · $4,950 USD

Market perspective

The global Valpromide market is projected to grow from US$ million in 2026 to US$ million by 2032, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.

The US & Canada market for Valpromide is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

Europe market for Valpromide is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

Read the full market overview

Asia-Pacific market for Valpromide is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

The China market for Valpromide is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

The major global manufacturers of Valpromide include Novartis Pharmaceuticals, Beijing Sail Biopharmaceutical Co., Ltd., Hunan Dino Pharmaceutical Co., Ltd., Hunan Hansen Pharmaceutical Co., Ltd., Hunan Xiangzhong Pharmaceutical Co., Ltd., China Resources Double-Crane Pharmaceutical Co., Ltd. and Shanxi Luliang Traditional Chinese Medicine Factory, etc. In 2025, the world's top three vendors accounted for approximately % of the revenue.

This report presents an overview of global market for Valpromide, sales, revenue and price. Analyses of the global market trends, with historic market revenue or sales data for 2021 - 2025, estimates for 2026, and projections of CAGR through 2032.

This report researches the key producers of Valpromide, also provides the sales of main regions and countries. Of the upcoming market potential for Valpromide, and key regions or countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.

This report focuses on the Valpromide sales, revenue, market share and industry ranking of main manufacturers, data from 2021 to 2026. Identification of the major stakeholders in the global Valpromide market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.

This report analyzes the segments data by Type and by Application, sales, revenue, and price, from 2021 to 2032. Evaluation and forecast the market size for Valpromide sales, projected growth trends, production technology, application and end-user industry.

Valpromide Segment by Company

Novartis Pharmaceuticals

Beijing Sail Biopharmaceutical Co., Ltd.

Hunan Dino Pharmaceutical Co., Ltd.

Hunan Hansen Pharmaceutical Co., Ltd.

Hunan Xiangzhong Pharmaceutical Co., Ltd.

China Resources Double-Crane Pharmaceutical Co., Ltd.

Shanxi Luliang Traditional Chinese Medicine Factory

Valpromide Segment by Type

Pill

Suppository

Capsule

Valpromide Segment by Application

Hospital

Pharmacy

Others

Valpromide Segment by Region

North America

United States

Canada

Europe

Germany

France

U.K.

Italy

Netherlands

Asia-Pacific

China

Japan

South Korea

India

Australia

China Taiwan

Southeast Asia

South America

Mexico

Brazil

Argentina

Middle East & Africa

Turkey

Saudi Arabia

UAE

Study Objectives

1. To analyze and research the global status and future forecast, involving growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, sales, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Valpromide market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Valpromide and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Valpromide.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by type and by application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Sales (consumption), revenue of Valpromide in global, regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.

Chapter 4: Detailed analysis of Valpromide manufacturers competitive landscape, price, sales, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.

Chapter 5: Provides the analysis of various market segments by type, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 6: Provides the analysis of various market segments by application, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 7: Provides profiles of key manufacturers, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Valpromide sales, revenue, price, gross margin, and recent development, etc.

Chapter 8: North America by type, by application and by country, sales, and revenue for each segment.

Chapter 9: Europe by type, by application and by country, sales, and revenue for each segment.

Chapter 10: China type, by application, sales, and revenue for each segment.

Chapter 11: Asia (excluding China) type, by application and by region, sales, and revenue for each segment.

Chapter 12: South America, Middle East and Africa by type, by application and by country, sales, and revenue for each segment.

Chapter 13: Analysis of industrial chain, sales channel, key raw materials, distributors and customers.

Chapter 14: The main concluding insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Global Valpromide Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Table 2. Pill Major Manufacturers Table 3. Suppository Major Manufacturers Table 4. Capsule Major Manufacturers Table 5. Global Valpromide Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Table 6. Hospital Major Manufacturers Table 7. Pharmacy Major Manufacturers Table 8. Others Major Manufacturers Table 9. Valpromide Industry Trends Table 10. Valpromide Industry Drivers Table 11. Valpromide Industry Opportunities and Challenges Table 12. Valpromide Industry Restraints Table 13. Global Valpromide Revenue Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 14. Global Valpromide Revenue by Region (2021-2026) & (US$ Million) Table 15. Global Valpromide Revenue by Region (2027-2032) & (US$ Million) Table 16. Global Valpromide Revenue Market Share by Region (2021-2026) Table 17. Global Valpromide Revenue Market Share by Region (2027-2032) Table 18. Global Valpromide Sales Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (K Units) Table 19. Global Valpromide Sales by Region (2021-2026) & (K Units) Table 20. Global Valpromide Sales by Region (2027-2032) & (K Units) Table 21. Global Valpromide Sales Market Share by Region (2021-2026) Table 22. Global Valpromide Sales Market Share by Region (2027-2032) Table 23. Global Valpromide Revenue by Manufacturers (US$ Million) & (2021-2026) Table 24. Global Valpromide Revenue Market Share by Manufacturers (2021-2026) Table 25. Global Valpromide Sales by Manufacturers (US$ Million) & (2021-2026) Table 26. Global Valpromide Sales Market Share by Manufacturers (2021-2026) Table 27. Global Valpromide Sales Price (US$/Unit) of Manufacturers (2021-2026) Table 28. Global Valpromide Key Manufacturers Ranking, 2024 VS 2025 VS 2026 Table 29. Global Valpromide Key Manufacturers Manufacturing Sites & Headquarters Table 30. Global Valpromide Manufacturers, Product Type & Application Table 31. Global Valpromide Manufacturers' Establishment Date Table 32. Global Manufacturers Market Concentration Ratio (CR5 and HHI) Table 33. Global Valpromide by Manufacturers Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 34. Global Valpromide Revenue by Type 2021 VS 2025 VS 2032 (US$ Million) Table 35. Global Valpromide Revenue by Type (2021-2026) & (US$ Million) Table 36. Global Valpromide Revenue by Type (2027-2032) & (US$ Million) Table 37. Global Valpromide Revenue Market Share by Type (2021-2026) Table 38. Global Valpromide Revenue Market Share by Type (2027-2032) Table 39. Global Valpromide Sales by Type 2021 VS 2025 VS 2032 (K Units) Table 40. Global Valpromide Sales by Type (2021-2026) & (K Units) Table 41. Global Valpromide Sales by Type (2027-2032) & (K Units) Table 42. Global Valpromide Sales Market Share by Type (2021-2026) Table 43. Global Valpromide Sales Market Share by Type (2027-2032) Table 44. Global Valpromide Price by Type (2021-2026) & (US$/Unit) Table 45. Global Valpromide Price by Type (2027-2032) & (US$/Unit) Table 46. Global Valpromide Revenue by Application 2021 VS 2025 VS 2032 (US$ Million) Table 47. Global Valpromide Revenue by Application (2021-2026) & (US$ Million) Table 48. Global Valpromide Revenue by Application (2027-2032) & (US$ Million) Table 49. Global Valpromide Revenue Market Share by Application (2021-2026) Table 50. Global Valpromide Revenue Market Share by Application (2027-2032) Table 51. Global Valpromide Sales by Application 2021 VS 2025 VS 2032 (K Units) Table 52. Global Valpromide Sales by Application (2021-2026) & (K Units) Table 53. Global Valpromide Sales by Application (2027-2032) & (K Units) Table 54. Global Valpromide Sales Market Share by Application (2021-2026) Table 55. Global Valpromide Sales Market Share by Application (2027-2032) Table 56. Global Valpromide Price by Application (2021-2026) & (US$/Unit) Table 57. Global Valpromide Price by Application (2027-2032) & (US$/Unit) Table 58. Novartis Pharmaceuticals Company Information Table 59. Novartis Pharmaceuticals Business Overview Table 60. Novartis Pharmaceuticals Valpromide Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 61. Novartis Pharmaceuticals Valpromide Product Portfolio Table 62. Novartis Pharmaceuticals Recent Development Table 63. Beijing Sail Biopharmaceutical Co., Ltd. Company Information Table 64. Beijing Sail Biopharmaceutical Co., Ltd. Business Overview Table 65. Beijing Sail Biopharmaceutical Co., Ltd. Valpromide Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 66. Beijing Sail Biopharmaceutical Co., Ltd. Valpromide Product Portfolio Table 67. Beijing Sail Biopharmaceutical Co., Ltd. Recent Development Table 68. Hunan Dino Pharmaceutical Co., Ltd. Company Information Table 69. Hunan Dino Pharmaceutical Co., Ltd. Business Overview Table 70. Hunan Dino Pharmaceutical Co., Ltd. Valpromide Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 71. Hunan Dino Pharmaceutical Co., Ltd. Valpromide Product Portfolio Table 72. Hunan Dino Pharmaceutical Co., Ltd. Recent Development Table 73. Hunan Hansen Pharmaceutical Co., Ltd. Company Information Table 74. Hunan Hansen Pharmaceutical Co., Ltd. Business Overview Table 75. Hunan Hansen Pharmaceutical Co., Ltd. Valpromide Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 76. Hunan Hansen Pharmaceutical Co., Ltd. Valpromide Product Portfolio Table 77. Hunan Hansen Pharmaceutical Co., Ltd. Recent Development Table 78. Hunan Xiangzhong Pharmaceutical Co., Ltd. Company Information Table 79. Hunan Xiangzhong Pharmaceutical Co., Ltd. Business Overview Table 80. Hunan Xiangzhong Pharmaceutical Co., Ltd. Valpromide Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 81. Hunan Xiangzhong Pharmaceutical Co., Ltd. Valpromide Product Portfolio Table 82. Hunan Xiangzhong Pharmaceutical Co., Ltd. Recent Development Table 83. China Resources Double-Crane Pharmaceutical Co., Ltd. Company Information Table 84. China Resources Double-Crane Pharmaceutical Co., Ltd. Business Overview Table 85. China Resources Double-Crane Pharmaceutical Co., Ltd. Valpromide Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 86. China Resources Double-Crane Pharmaceutical Co., Ltd. Valpromide Product Portfolio Table 87. China Resources Double-Crane Pharmaceutical Co., Ltd. Recent Development Table 88. Shanxi Luliang Traditional Chinese Medicine Factory Company Information Table 89. Shanxi Luliang Traditional Chinese Medicine Factory Business Overview Table 90. Shanxi Luliang Traditional Chinese Medicine Factory Valpromide Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 91. Shanxi Luliang Traditional Chinese Medicine Factory Valpromide Product Portfolio Table 92. Shanxi Luliang Traditional Chinese Medicine Factory Recent Development Table 93. North America Valpromide Revenue by Type (2021-2026) & (US$ Million) Table 94. North America Valpromide Revenue by Type (2027-2032) & (US$ Million) Table 95. North America Valpromide Sales by Type (2021-2026) & (K Units) Table 96. North America Valpromide Sales by Type (2027-2032) & (K Units) Table 97. North America Valpromide Sales Price by Type (2021-2026) & (US$/Unit) Table 98. North America Valpromide Sales Price by Type (2027-2032) & (US$/Unit) Table 99. North America Valpromide Revenue by Application (2021-2026) & (US$ Million) Table 100. North America Valpromide Revenue by Application (2027-2032) & (US$ Million) Table 101. North America Valpromide Sales by Application (2021-2026) & (K Units) Table 102. North America Valpromide Sales by Application (2027-2032) & (K Units) Table 103. North America Valpromide Sales Price by Application (2021-2026) & (US$/Unit) Table 104. North America Valpromide Sales Price by Application (2027-2032) & (US$/Unit) Table 105. North America Valpromide Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 106. North America Valpromide Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 107. North America Valpromide Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 108. North America Valpromide Sales by Country (2021 VS 2025 VS 2032) & (K Units) Table 109. North America Valpromide Sales by Country (2021-2026) & (K Units) Table 110. North America Valpromide Sales by Country (2027-2032) & (K Units) Table 111. North America Valpromide Sales Price by Country (2021-2026) & (US$/Unit) Table 112. North America Valpromide Sales Price by Country (2027-2032) & (US$/Unit) Table 113. United States Valpromide Revenue (2021-2032) & (US$ Million) Table 114. Canada Valpromide Revenue (2021-2032) & (US$ Million) Table 115. Europe Valpromide Revenue by Type (2021-2026) & (US$ Million) Table 116. Europe Valpromide Revenue by Type (2027-2032) & (US$ Million) Table 117. Europe Valpromide Sales by Type (2021-2026) & (K Units) Table 118. Europe Valpromide Sales by Type (2027-2032) & (K Units) Table 119. Europe Valpromide Sales Price by Type (2021-2026) & (US$/Unit) Table 120. Europe Valpromide Sales Price by Type (2027-2032) & (US$/Unit) Table 121. Europe Valpromide Revenue by Application (2021-2026) & (US$ Million) Table 122. Europe Valpromide Revenue by Application (2027-2032) & (US$ Million) Table 123. Europe Valpromide Sales by Application (2021-2026) & (K Units) Table 124. Europe Valpromide Sales by Application (2027-2032) & (K Units) Table 125. Europe Valpromide Sales Price by Application (2021-2026) & (US$/Unit) Table 126. Europe Valpromide Sales Price by Application (2027-2032) & (US$/Unit) Table 127. Europe Valpromide Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 128. Europe Valpromide Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 129. Europe Valpromide Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 130. Europe Valpromide Sales by Country (2021 VS 2025 VS 2032) & (K Units) Table 131. Europe Valpromide Sales by Country (2021-2026) & (K Units) Table 132. Europe Valpromide Sales by Country (2027-2032) & (K Units) Table 133. Europe Valpromide Sales Price by Country (2021-2026) & (US$/Unit) Table 134. Europe Valpromide Sales Price by Country (2027-2032) & (US$/Unit) Table 135. Germany Valpromide Revenue (2021-2032) & (US$ Million) Table 136. France Valpromide Revenue (2021-2032) & (US$ Million) Table 137. U.K. Valpromide Revenue (2021-2032) & (US$ Million) Table 138. Italy Valpromide Revenue (2021-2032) & (US$ Million) Table 139. Netherlands Valpromide Revenue (2021-2032) & (US$ Million) Table 140. China Valpromide Revenue by Type (2021-2026) & (US$ Million) Table 141. China Valpromide Revenue by Type (2027-2032) & (US$ Million) Table 142. China Valpromide Sales by Type (2021-2026) & (K Units) Table 143. China Valpromide Sales by Type (2027-2032) & (K Units) Table 144. China Valpromide Sales Price by Type (2021-2026) & (US$/Unit) Table 145. China Valpromide Sales Price by Type (2027-2032) & (US$/Unit) Table 146. China Valpromide Revenue by Application (2021-2026) & (US$ Million) Table 147. China Valpromide Revenue by Application (2027-2032) & (US$ Million) Table 148. China Valpromide Sales by Application (2021-2026) & (K Units) Table 149. China Valpromide Sales by Application (2027-2032) & (K Units) Table 150. China Valpromide Sales Price by Application (2021-2026) & (US$/Unit) Table 151. China Valpromide Sales Price by Application (2027-2032) & (US$/Unit) Table 152. Asia Valpromide Revenue by Type (2021-2026) & (US$ Million) Table 153. Asia Valpromide Revenue by Type (2027-2032) & (US$ Million) Table 154. Asia Valpromide Sales by Type (2021-2026) & (K Units) Table 155. Asia Valpromide Sales by Type (2027-2032) & (K Units) Table 156. Asia Valpromide Sales Price by Type (2021-2026) & (US$/Unit) Table 157. Asia Valpromide Sales Price by Type (2027-2032) & (US$/Unit) Table 158. Asia Valpromide Revenue by Application (2021-2026) & (US$ Million) Table 159. Asia Valpromide Revenue by Application (2027-2032) & (US$ Million) Table 160. Asia Valpromide Sales by Application (2021-2026) & (K Units) Table 161. Asia Valpromide Sales by Application (2027-2032) & (K Units) Table 162. Asia Valpromide Sales Price by Application (2021-2026) & (US$/Unit) Table 163. Asia Valpromide Sales Price by Application (2027-2032) & (US$/Unit) Table 164. Asia Valpromide Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 165. Asia Valpromide Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 166. Asia Valpromide Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 167. Asia Valpromide Sales by Country (2021 VS 2025 VS 2032) & (K Units) Table 168. Asia Valpromide Sales by Country (2021-2026) & (K Units) Table 169. Asia Valpromide Sales by Country (2027-2032) & (K Units) Table 170. Asia Valpromide Sales Price by Country (2021-2026) & (US$/Unit) Table 171. Asia Valpromide Sales Price by Country (2027-2032) & (US$/Unit) Table 172. Japan Valpromide Revenue (2021-2032) & (US$ Million) Table 173. South Korea Valpromide Revenue (2021-2032) & (US$ Million) Table 174. India Valpromide Revenue (2021-2032) & (US$ Million) Table 175. Australia Valpromide Revenue (2021-2032) & (US$ Million) Table 176. China Taiwan Valpromide Revenue (2021-2032) & (US$ Million) Table 177. Southeast Asia Valpromide Revenue (2021-2032) & (US$ Million) Table 178. SAMEA Valpromide Revenue by Type (2021-2026) & (US$ Million) Table 179. SAMEA Valpromide Revenue by Type (2027-2032) & (US$ Million) Table 180. SAMEA Valpromide Sales by Type (2021-2026) & (K Units) Table 181. SAMEA Valpromide Sales by Type (2027-2032) & (K Units) Table 182. SAMEA Valpromide Sales Price by Type (2021-2026) & (US$/Unit) Table 183. SAMEA Valpromide Sales Price by Type (2027-2032) & (US$/Unit) Table 184. SAMEA Valpromide Revenue by Application (2021-2026) & (US$ Million) Table 185. SAMEA Valpromide Revenue by Application (2027-2032) & (US$ Million) Table 186. SAMEA Valpromide Sales by Application (2021-2026) & (K Units) Table 187. SAMEA Valpromide Sales by Application (2027-2032) & (K Units) Table 188. SAMEA Valpromide Sales Price by Application (2021-2026) & (US$/Unit) Table 189. SAMEA Valpromide Sales Price by Application (2027-2032) & (US$/Unit) Table 190. SAMEA Valpromide Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 191. SAMEA Valpromide Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 192. SAMEA Valpromide Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 193. SAMEA Valpromide Sales by Country (2021 VS 2025 VS 2032) & (K Units) Table 194. SAMEA Valpromide Sales by Country (2021-2026) & (K Units) Table 195. SAMEA Valpromide Sales by Country (2027-2032) & (K Units) Table 196. SAMEA Valpromide Sales Price by Country (2021-2026) & (US$/Unit) Table 197. SAMEA Valpromide Sales Price by Country (2027-2032) & (US$/Unit) Table 198. Brazil Valpromide Revenue (2021-2032) & (US$ Million) Table 199. Argentina Valpromide Revenue (2021-2032) & (US$ Million) Table 200. Chile Valpromide Revenue (2021-2032) & (US$ Million) Table 201. Colombia Valpromide Revenue (2021-2032) & (US$ Million) Table 202. Peru Valpromide Revenue (2021-2032) & (US$ Million) Table 203. Saudi Arabia Valpromide Revenue (2021-2032) & (US$ Million) Table 204. Israel Valpromide Revenue (2021-2032) & (US$ Million) Table 205. UAE Valpromide Revenue (2021-2032) & (US$ Million) Table 206. Turkey Valpromide Revenue (2021-2032) & (US$ Million) Table 207. Iran Valpromide Revenue (2021-2032) & (US$ Million) Table 208. Egypt Valpromide Revenue (2021-2032) & (US$ Million) Table 209. Key Raw Materials Table 210. Raw Materials Key Suppliers Table 211. Valpromide Distributors List Table 212. Valpromide Customers List Table 213. Research Programs/Design for This Report Table 214. Authors List of This Report Table 215. Secondary Sources Table 216. Primary Sources List of Figures Figure 1. Valpromide Image Figure 2. Global Valpromide Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Valpromide Market Size Share 2021 VS 2025 VS 2032 Figure 4. Pill Image Figure 5. Suppository Image Figure 6. Capsule Image Figure 7. Global Valpromide Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Figure 8. Global Valpromide Market Size Share 2021 VS 2025 VS 2032 Figure 9. Hospital Image Figure 10. Pharmacy Image Figure 11. Others Image Figure 12. Global Valpromide Revenue (US$ Million), 2021 VS 2025 VS 2032 Figure 13. Global Valpromide Revenue (2021-2032) & (US$ Million) Figure 14. Global Valpromide Revenue (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 15. Global Valpromide Revenue Market Share by Region: 2025 Versus 2032 Figure 16. Global Valpromide Revenue Market Share by Region (2021-2032) Figure 17. Global Valpromide Sales (2021-2032) & (K Units) Figure 18. Global Valpromide Sales by Region: 2021 VS 2025 VS 2032 (K Units) Figure 19. Global Valpromide Sales Market Share by Region (2021-2032) Figure 20. US & Canada & Mexico Valpromide Sales YoY (2021-2032) & (K Units) Figure 21. Europe Valpromide Sales YoY (2021-2032) & (K Units) Figure 22. China Valpromide Sales YoY (2021-2032) & (K Units) Figure 23. Asia (Excluding China) Valpromide Sales YoY (2021-2032) & (K Units) Figure 24. South America, Middle East and Africa Valpromide Sales YoY (2021-2032) & (K Units) Figure 25. Global Valpromide Manufacturers Revenue Share Top 10 and Top 5 in 2025 Figure 26. Global Valpromide Manufacturers Sales Share Top 10 and Top 5 in 2025 Figure 27. Manufacturers Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 28. Global Valpromide Revenue by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 29. Global Valpromide Revenue Market Share by Type 2021 VS 2025 VS 2032 Figure 30. Global Valpromide Revenue Market Share by Type (2021-2032) Figure 31. Global Valpromide Sales by Type (2021 VS 2025 VS 2032) & (K Units) Figure 32. Global Valpromide Sales Market Share by Type 2021 VS 2025 VS 2032 Figure 33. Global Valpromide Sales Market Share by Type (2021-2032) Figure 34. Global Valpromide Revenue by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 35. Global Valpromide Revenue Market Share by Application 2021 VS 2025 VS 2032 Figure 36. Global Valpromide Revenue Market Share by Application (2021-2032) Figure 37. Global Valpromide Sales by Application (2021 VS 2025 VS 2032) & (K Units) Figure 38. Global Valpromide Sales Market Share by Application 2021 VS 2025 VS 2032 Figure 39. Global Valpromide Sales Market Share by Application (2021-2032) Figure 40. North America Valpromide Revenue Share by Type (2021-2032) Figure 41. North America Valpromide Sales Share by Type (2021-2032) Figure 42. North America Valpromide Revenue Share by Application (2021-2032) Figure 43. North America Valpromide Sales Share by Application (2021-2032) Figure 44. North America Valpromide Revenue Share by Country (2021-2032) Figure 45. North America Valpromide Sales Share by Country (2021-2032) Figure 46. Europe Valpromide Revenue Share by Type (2021-2032) Figure 47. Europe Valpromide Sales Share by Type (2021-2032) Figure 48. Europe Valpromide Revenue Share by Application (2021-2032) Figure 49. Europe Valpromide Sales Share by Application (2021-2032) Figure 50. Europe Valpromide Revenue Share by Country (2021-2032) Figure 51. Europe Valpromide Sales Share by Country (2021-2032) Figure 52. China Valpromide Revenue Share by Type (2021-2032) Figure 53. China Valpromide Sales Share by Type (2021-2032) Figure 54. China Valpromide Revenue Share by Application (2021-2032) Figure 55. China Valpromide Sales Share by Application (2021-2032) Figure 56. Asia Valpromide Revenue Share by Type (2021-2032) Figure 57. Asia Valpromide Sales Share by Type (2021-2032) Figure 58. Asia Valpromide Revenue Share by Application (2021-2032) Figure 59. Asia Valpromide Sales Share by Application (2021-2032) Figure 60. Asia Valpromide Revenue Share by Country (2021-2032) Figure 61. Asia Valpromide Sales Share by Country (2021-2032) Figure 62. SAMEA Valpromide Revenue Share by Type (2021-2032) Figure 63. SAMEA Valpromide Sales Share by Type (2021-2032) Figure 64. SAMEA Valpromide Revenue Share by Application (2021-2032) Figure 65. SAMEA Valpromide Sales Share by Application (2021-2032) Figure 66. SAMEA Valpromide Revenue Share by Country (2021-2032) Figure 67. SAMEA Valpromide Sales Share by Country (2021-2032) Figure 68. Valpromide Value Chain Figure 69. Manufacturing Cost Structure Figure 70. Valpromide Production Mode & Process Figure 71. Direct Comparison with Distribution Share Figure 72. Distributors Profiles Figure 73. Years Considered Figure 74. Research Process Figure 75. Key Executives Interviewed

Scope & coverage.

Types
  • Pill
  • Suppository
  • Capsule
Applications
  • Hospital
  • Pharmacy
  • Others
Companies covered
  • Novartis Pharmaceuticals
  • Beijing Sail Biopharmaceutical Co., Ltd.
  • Hunan Dino Pharmaceutical Co., Ltd.
  • Hunan Hansen Pharmaceutical Co., Ltd.
  • Hunan Xiangzhong Pharmaceutical Co., Ltd.
  • China Resources Double-Crane Pharmaceutical Co., Ltd.
  • Shanxi Luliang Traditional Chinese Medicine Factory

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Valpromide Market by Type
  3. 1.2.1 Global Valpromide Market Size by Type, 2021 VS 2025 VS 2032
  4. 1.2.2 Pill
  5. 1.2.3 Suppository
  6. 1.2.4 Capsule
  7. 1.3 Valpromide Market by Application
  8. 1.3.1 Global Valpromide Market Size by Application, 2021 VS 2025 VS 2032
  9. 1.3.2 Hospital
  10. 1.3.3 Pharmacy
  11. 1.3.4 Others
  12. 1.4 Assumptions and Limitations
  13. 1.5 Study Goals and Objectives
2 Valpromide Market Dynamics
  1. 2.1 Valpromide Industry Trends
  2. 2.2 Valpromide Industry Drivers
  3. 2.3 Valpromide Industry Opportunities and Challenges
  4. 2.4 Valpromide Industry Restraints
3 Global Market Growth Prospects
  1. 3.1 Global Valpromide Revenue Estimates and Forecasts (2021-2032)
  2. 3.2 Global Valpromide Revenue by Region
  3. 3.2.1 Global Valpromide Revenue by Region: 2021 VS 2025 VS 2032
  4. 3.2.2 Global Valpromide Revenue by Region (2021-2026)
  5. 3.2.3 Global Valpromide Revenue by Region (2027-2032)
  6. 3.2.4 Global Valpromide Revenue Market Share by Region (2021-2032)
  7. 3.3 Global Valpromide Sales Estimates and Forecasts 2021-2032
  8. 3.4 Global Valpromide Sales by Region
  9. 3.4.1 Global Valpromide Sales by Region: 2021 VS 2025 VS 2032
  10. 3.4.2 Global Valpromide Sales by Region (2021-2026)
  11. 3.4.3 Global Valpromide Sales by Region (2027-2032)
  12. 3.4.4 Global Valpromide Sales Market Share by Region (2021-2032)
  13. 3.5 US & Canada & Mexico
  14. 3.6 Europe
  15. 3.7 China
  16. 3.8 Asia (Excluding China)
  17. 3.9 South America, Middle East and Africa
4 Market Competitive Landscape by Manufacturers
  1. 4.1 Global Valpromide Revenue by Manufacturers
  2. 4.1.1 Global Valpromide Revenue by Manufacturers (2021-2026)
  3. 4.1.2 Global Valpromide Revenue Market Share by Manufacturers (2021-2026)
  4. 4.1.3 Global Valpromide Manufacturers Revenue Share Top 10 and Top 5 in 2025
  5. 4.2 Global Valpromide Sales by Manufacturers
  6. 4.2.1 Global Valpromide Sales by Manufacturers (2021-2026)
  7. 4.2.2 Global Valpromide Sales Market Share by Manufacturers (2021-2026)
  8. 4.2.3 Global Valpromide Manufacturers Sales Share Top 10 and Top 5 in 2025
  9. 4.3 Global Valpromide Sales Price by Manufacturers (2021-2026)
  10. 4.4 Global Valpromide Key Manufacturers Ranking, 2024 VS 2025 VS 2026
  11. 4.5 Global Valpromide Key Manufacturers Manufacturing Sites & Headquarters
  12. 4.6 Global Valpromide Manufacturers, Product Type & Application
  13. 4.7 Global Valpromide Manufacturers' Establishment Date
  14. 4.8 Market Competitive Analysis
  15. 4.8.1 Global Valpromide Market CR5 and HHI
  16. 4.8.2 2025 Valpromide Tier 1, Tier 2, and Tier 3
5 Valpromide Market by Type
  1. 5.1 Global Valpromide Revenue by Type
  2. 5.1.1 Global Valpromide Revenue by Type (2021 VS 2025 VS 2032)
  3. 5.1.2 Global Valpromide Revenue by Type (2021-2032) & (US$ Million)
  4. 5.1.3 Global Valpromide Revenue Market Share by Type (2021-2032)
  5. 5.2 Global Valpromide Sales by Type
  6. 5.2.1 Global Valpromide Sales by Type (2021 VS 2025 VS 2032)
  7. 5.2.2 Global Valpromide Sales by Type (2021-2032) & (K Units)
  8. 5.2.3 Global Valpromide Sales Market Share by Type (2021-2032)
  9. 5.3 Global Valpromide Price by Type
6 Valpromide Market by Application
  1. 6.1 Global Valpromide Revenue by Application
  2. 6.1.1 Global Valpromide Revenue by Application (2021 VS 2025 VS 2032)
  3. 6.1.2 Global Valpromide Revenue by Application (2021-2032) & (US$ Million)
  4. 6.1.3 Global Valpromide Revenue Market Share by Application (2021-2032)
  5. 6.2 Global Valpromide Sales by Application
  6. 6.2.1 Global Valpromide Sales by Application (2021 VS 2025 VS 2032)
  7. 6.2.2 Global Valpromide Sales by Application (2021-2032) & (K Units)
  8. 6.2.3 Global Valpromide Sales Market Share by Application (2021-2032)
  9. 6.3 Global Valpromide Price by Application
7 Company Profiles
  1. 7.1 Novartis Pharmaceuticals
  2. 7.1.1 Novartis Pharmaceuticals Company Information
  3. 7.1.2 Novartis Pharmaceuticals Business Overview
  4. 7.1.3 Novartis Pharmaceuticals Valpromide Sales, Revenue, Price and Gross Margin (2021-2026)
  5. 7.1.4 Novartis Pharmaceuticals Valpromide Product Portfolio
  6. 7.1.5 Novartis Pharmaceuticals Recent Developments
  7. 7.2 Beijing Sail Biopharmaceutical Co., Ltd.
  8. 7.2.1 Beijing Sail Biopharmaceutical Co., Ltd. Company Information
  9. 7.2.2 Beijing Sail Biopharmaceutical Co., Ltd. Business Overview
  10. 7.2.3 Beijing Sail Biopharmaceutical Co., Ltd. Valpromide Sales, Revenue, Price and Gross Margin (2021-2026)
  11. 7.2.4 Beijing Sail Biopharmaceutical Co., Ltd. Valpromide Product Portfolio
  12. 7.2.5 Beijing Sail Biopharmaceutical Co., Ltd. Recent Developments
  13. 7.3 Hunan Dino Pharmaceutical Co., Ltd.
  14. 7.3.1 Hunan Dino Pharmaceutical Co., Ltd. Company Information
  15. 7.3.2 Hunan Dino Pharmaceutical Co., Ltd. Business Overview
  16. 7.3.3 Hunan Dino Pharmaceutical Co., Ltd. Valpromide Sales, Revenue, Price and Gross Margin (2021-2026)
  17. 7.3.4 Hunan Dino Pharmaceutical Co., Ltd. Valpromide Product Portfolio
  18. 7.3.5 Hunan Dino Pharmaceutical Co., Ltd. Recent Developments
  19. 7.4 Hunan Hansen Pharmaceutical Co., Ltd.
  20. 7.4.1 Hunan Hansen Pharmaceutical Co., Ltd. Company Information
  21. 7.4.2 Hunan Hansen Pharmaceutical Co., Ltd. Business Overview
  22. 7.4.3 Hunan Hansen Pharmaceutical Co., Ltd. Valpromide Sales, Revenue, Price and Gross Margin (2021-2026)
  23. 7.4.4 Hunan Hansen Pharmaceutical Co., Ltd. Valpromide Product Portfolio
  24. 7.4.5 Hunan Hansen Pharmaceutical Co., Ltd. Recent Developments
  25. 7.5 Hunan Xiangzhong Pharmaceutical Co., Ltd.
  26. 7.5.1 Hunan Xiangzhong Pharmaceutical Co., Ltd. Company Information
  27. 7.5.2 Hunan Xiangzhong Pharmaceutical Co., Ltd. Business Overview
  28. 7.5.3 Hunan Xiangzhong Pharmaceutical Co., Ltd. Valpromide Sales, Revenue, Price and Gross Margin (2021-2026)
  29. 7.5.4 Hunan Xiangzhong Pharmaceutical Co., Ltd. Valpromide Product Portfolio
  30. 7.5.5 Hunan Xiangzhong Pharmaceutical Co., Ltd. Recent Developments
  31. 7.6 China Resources Double-Crane Pharmaceutical Co., Ltd.
  32. 7.6.1 China Resources Double-Crane Pharmaceutical Co., Ltd. Company Information
  33. 7.6.2 China Resources Double-Crane Pharmaceutical Co., Ltd. Business Overview
  34. 7.6.3 China Resources Double-Crane Pharmaceutical Co., Ltd. Valpromide Sales, Revenue, Price and Gross Margin (2021-2026)
  35. 7.6.4 China Resources Double-Crane Pharmaceutical Co., Ltd. Valpromide Product Portfolio
  36. 7.6.5 China Resources Double-Crane Pharmaceutical Co., Ltd. Recent Developments
  37. 7.7 Shanxi Luliang Traditional Chinese Medicine Factory
  38. 7.7.1 Shanxi Luliang Traditional Chinese Medicine Factory Company Information
  39. 7.7.2 Shanxi Luliang Traditional Chinese Medicine Factory Business Overview
  40. 7.7.3 Shanxi Luliang Traditional Chinese Medicine Factory Valpromide Sales, Revenue, Price and Gross Margin (2021-2026)
  41. 7.7.4 Shanxi Luliang Traditional Chinese Medicine Factory Valpromide Product Portfolio
  42. 7.7.5 Shanxi Luliang Traditional Chinese Medicine Factory Recent Developments
8 North America
  1. 8.1 North America Valpromide Market Size by Type
  2. 8.1.1 North America Valpromide Revenue by Type (2021-2032)
  3. 8.1.2 North America Valpromide Sales by Type (2021-2032)
  4. 8.1.3 North America Valpromide Price by Type (2021-2032)
  5. 8.2 North America Valpromide Market Size by Application
  6. 8.2.1 North America Valpromide Revenue by Application (2021-2032)
  7. 8.2.2 North America Valpromide Sales by Application (2021-2032)
  8. 8.2.3 North America Valpromide Price by Application (2021-2032)
  9. 8.3 North America Valpromide Market Size by Country
  10. 8.3.1 North America Valpromide Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 8.3.2 North America Valpromide Sales by Country (2021 VS 2025 VS 2032)
  12. 8.3.3 North America Valpromide Price by Country (2021-2032)
  13. 8.3.4 United States
  14. 8.3.5 Canada
9 Europe
  1. 9.1 Europe Valpromide Market Size by Type
  2. 9.1.1 Europe Valpromide Revenue by Type (2021-2032)
  3. 9.1.2 Europe Valpromide Sales by Type (2021-2032)
  4. 9.1.3 Europe Valpromide Price by Type (2021-2032)
  5. 9.2 Europe Valpromide Market Size by Application
  6. 9.2.1 Europe Valpromide Revenue by Application (2021-2032)
  7. 9.2.2 Europe Valpromide Sales by Application (2021-2032)
  8. 9.2.3 Europe Valpromide Price by Application (2021-2032)
  9. 9.3 Europe Valpromide Market Size by Country
  10. 9.3.1 Europe Valpromide Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 9.3.2 Europe Valpromide Sales by Country (2021 VS 2025 VS 2032)
  12. 9.3.3 Europe Valpromide Price by Country (2021-2032)
  13. 9.3.4 Germany
  14. 9.3.5 France
  15. 9.3.6 U.K.
  16. 9.3.7 Italy
  17. 9.3.8 Netherlands
10 China
  1. 10.1 China Valpromide Market Size by Type
  2. 10.1.1 China Valpromide Revenue by Type (2021-2032)
  3. 10.1.2 China Valpromide Sales by Type (2021-2032)
  4. 10.1.3 China Valpromide Price by Type (2021-2032)
  5. 10.2 China Valpromide Market Size by Application
  6. 10.2.1 China Valpromide Revenue by Application (2021-2032)
  7. 10.2.2 China Valpromide Sales by Application (2021-2032)
  8. 10.2.3 China Valpromide Price by Application (2021-2032)
11 Asia (Excluding China)
  1. 11.1 Asia Valpromide Market Size by Type
  2. 11.1.1 Asia Valpromide Revenue by Type (2021-2032)
  3. 11.1.2 Asia Valpromide Sales by Type (2021-2032)
  4. 11.1.3 Asia Valpromide Price by Type (2021-2032)
  5. 11.2 Asia Valpromide Market Size by Application
  6. 11.2.1 Asia Valpromide Revenue by Application (2021-2032)
  7. 11.2.2 Asia Valpromide Sales by Application (2021-2032)
  8. 11.2.3 Asia Valpromide Price by Application (2021-2032)
  9. 11.3 Asia Valpromide Market Size by Country
  10. 11.3.1 Asia Valpromide Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 11.3.2 Asia Valpromide Sales by Country (2021 VS 2025 VS 2032)
  12. 11.3.3 Asia Valpromide Price by Country (2021-2032)
  13. 11.3.4 Japan
  14. 11.3.5 South Korea
  15. 11.3.6 India
  16. 11.3.7 Australia
  17. 11.3.8 Taiwan
  18. 11.3.9 Southeast Asia
12 South America, Middle East and Africa
  1. 12.1 SAMEA Valpromide Market Size by Type
  2. 12.1.1 SAMEA Valpromide Revenue by Type (2021-2032)
  3. 12.1.2 SAMEA Valpromide Sales by Type (2021-2032)
  4. 12.1.3 SAMEA Valpromide Price by Type (2021-2032)
  5. 12.2 SAMEA Valpromide Market Size by Application
  6. 12.2.1 SAMEA Valpromide Revenue by Application (2021-2032)
  7. 12.2.2 SAMEA Valpromide Sales by Application (2021-2032)
  8. 12.2.3 SAMEA Valpromide Price by Application (2021-2032)
  9. 12.3 SAMEA Valpromide Market Size by Country
  10. 12.3.1 SAMEA Valpromide Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 12.3.2 SAMEA Valpromide Sales by Country (2021 VS 2025 VS 2032)
  12. 12.3.3 SAMEA Valpromide Price by Country (2021-2032)
  13. 12.3.4 Brazil
  14. 12.3.5 Argentina
  15. 12.3.6 Chile
  16. 12.3.7 Colombia
  17. 12.3.8 Peru
  18. 12.3.9 Saudi Arabia
  19. 12.3.10 Israel
  20. 12.3.11 UAE
  21. 12.3.12 Turkey
  22. 12.3.13 Iran
  23. 12.3.14 Egypt
13 Value Chain and Sales Channels Analysis
  1. 13.1 Valpromide Value Chain Analysis
  2. 13.1.1 Valpromide Key Raw Materials
  3. 13.1.2 Raw Materials Key Suppliers
  4. 13.1.3 Manufacturing Cost Structure
  5. 13.1.4 Valpromide Production Mode & Process
  6. 13.2 Valpromide Sales Channels Analysis
  7. 13.2.1 Direct Comparison with Distribution Share
  8. 13.2.2 Valpromide Distributors
  9. 13.2.3 Valpromide Customers
14 Concluding Insights
    15 Appendix
    1. 15.1 Reasons for Doing This Study
    2. 15.2 Research Methodology
    3. 15.3 Research Process
    4. 15.4 Authors List of This Report
    5. 15.5 Data Source
    6. 15.5.1 Secondary Sources
    7. 15.5.2 Primary Sources
    8. 15.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst